Peptide deformylase inhibitors as antibacterial agents: Identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach

被引:49
作者
Chen, D
Hackbarth, C
Ni, ZJ
Wu, C
Wang, W
Jain, R
He, Y
Bracken, K
Weidmann, B
Patel, DV
Trias, J
White, RJ
Yuan, Z
机构
[1] Vicuron Pharmaceut, Fremont, CA 94555 USA
[2] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1128/AAC.48.1.250-261.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Peptide deformylase (PDF), a metallohydrolase essential for bacterial growth, is an attractive target for use in the discovery of novel antibiotics. Focused chelator-based chemical libraries were constructed and screened for inhibition of enzymatic activity, inhibition of Staphylococcus aureus growth, and cytotoxicity. Positive compounds were selected based on the results of all three assays. VRC3375 [N-hydroxy-3-R-butyl-3-(2-S-(tertbutoxycarbonyl)-pyrrolidin-1-ylcarbonyl)propionamide] was identified as having the most favorable properties through an integrated combinatorial and medicinal chemistry effort. This compound is a potent PDF inhibitor with a K-i of 0.24 nM against the Escherichia coli Ni2+ enzyme, possesses activity against gram-positive and gram-negative bacterial pathogens, and has a low cytotoxicity. Mechanistic experiments demonstrate that the compound inhibits bacterial growth through PDF inhibition. Pharmacokinetic studies of this drug in mice indicate that VRC3375 is orally bioavailable and rapidly distributed among various tissues. VRC3375 has in vivo activity against S. aureus in a murine septicemia model, with 50% effective doses of 32, 17, and 21 mg/kg of body weight after dosing by intravenous (i.v.), subcutaneous (s.c.), and oral (p.o.) administration, respectively. In murine single-dose toxicity studies, no adverse effects were observed after dosing with more than 400 mg of VRC3375 per kg by i.v., p.o., or s.c. administration. The in vivo efficacy and low toxicity of VRC3375 suggest the potential for developing this class of compounds to be used in future antibacterial drugs.
引用
收藏
页码:250 / 261
页数:12
相关论文
共 32 条
[1]   N-FORMYLMETHIONYL-SRNA AS INITIATOR OF PROTEIN SYNTHESIS [J].
ADAMS, JM ;
CAPECCHI, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 55 (01) :147-&
[2]   ON RELEASE OF FORMYL GROUP FROM NASCENT PROTEIN [J].
ADAMS, JM .
JOURNAL OF MOLECULAR BIOLOGY, 1968, 33 (03) :571-&
[3]  
[Anonymous], 2000, M7A5 NAT COMM CLIN L, pM7
[4]   Iron center, substrate recognition and mechanism of peptide deformylase [J].
Becker, A ;
Schlichting, I ;
Kabsch, W ;
Groche, D ;
Schultz, S ;
Wagner, AFV .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (12) :1053-1058
[5]  
BROUGHTON BJ, 1975, J CHEM SOC P1, V9, P857
[6]   Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor [J].
Chen, DZ ;
Patel, DV ;
Hackbarth, CJ ;
Wang, W ;
Dreyer, G ;
Young, DC ;
Margolis, PS ;
Wu, C ;
Ni, ZJ ;
Trias, J ;
White, RJ ;
Yuan, ZY .
BIOCHEMISTRY, 2000, 39 (06) :1256-1262
[7]   Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor [J].
Clements, JM ;
Beckett, RP ;
Brown, A ;
Catlin, G ;
Lobell, M ;
Palan, S ;
Thomas, W ;
Whittaker, M ;
Wood, S ;
Salama, S ;
Baker, PJ ;
Rodgers, HF ;
Barynin, V ;
Rice, DW ;
Hunter, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :563-570
[8]   Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents [J].
Giglione, C ;
Pierre, M ;
Meinnel, T .
MOLECULAR MICROBIOLOGY, 2000, 36 (06) :1197-1205
[9]   Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site [J].
Groche, D ;
Becker, A ;
Schlichting, I ;
Kabsch, W ;
Schultz, S ;
Wagner, AFV .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (02) :342-346
[10]   The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: A platform for the structure-based design of antibacterial agents [J].
Guilloteau, JP ;
Mathieu, M ;
Giglione, C ;
Blanc, V ;
Dupuy, A ;
Chevrier, M ;
Gil, P ;
Famechon, A ;
Meinnel, T ;
Mikol, V .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (05) :951-962